The Impact of a Dedicated Sedation Team on the Incidence of Complications in Paediatric Procedural Analgosedation
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 784
- Primary Endpoint
- Incidence of adverse events
Study Overview
Brief Summary
At a tertiary care university hospital a specialized interdisciplinary team of paediatric anaesthesiologists and paediatric intensivists was established for providing analgosedation for diagnostic and therapeutic procedures. The aim of the present study was to analyse the incidence and risk factors of adverse events during procedural sedation performed by the Children's Analgosedation Team (CAST).
Detailed Description
At a tertiary care university hospital a dedicated Children's Analgosedation Team (CAST) performs all procedural sedations in children outside the operating room. Often patient age, comorbidities and procedures involving the airway are considered risk factors for adverse events, but previous studies investigating adverse events did not involve implementation of a specialised sedation team. Medical records of all children receiving procedural sedation by the CAST were reviewed for the incidence of adverse events. A bivariate analysis as well as an analysis of variance using type II Wald chi-square tests were conducted for identifying potential risk factors for adverse Events.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Children (age 0-20 years) receiving procedural sedation
- •Procedural sedation performed by the Children's Analgosedation Team
Exclusion Criteria
- •Missing medical records
- •Procedural sedation not performed by the Children's Analgosedation Team
Outcomes
Primary Outcomes
Incidence of adverse events
Time Frame: From the beginning of sedation (administration of 1. sedation drug) until the end of sedation (patient regained consciousness), assessed up to 6 hours
Respiratory, hemodynamic, and other adverse events
Secondary Outcomes
- Upper respiratory tract infection (URI)(At the beginning of sedation (administration of 1. sedation drug))
- Type and dose of sedative(From the beginning of sedation (administration of 1. sedation drug) until the end of sedation (patient regained consciousness), assessed up to 6 hours)
- American Society of Anesthesiology (ASA) status(At the beginning of sedation (administration of 1. sedation drug))
- Age(At the beginning of sedation (administration of 1. sedation drug))
- Date of sedation(At the beginning of sedation (administration of 1. sedation drug))
- Category of the primary diagnosis(At the beginning of sedation (administration of 1. sedation drug))
- Incidence of serious adverse events(From the beginning of sedation (administration of 1. sedation drug) until the end of sedation (patient regained consciousness), assessed up to 6 hours)
- Sex(At the beginning of sedation (administration of 1. sedation drug))
- Type and dose of analgesic(From the beginning of sedation (administration of 1. sedation drug) until the end of sedation (patient regained consciousness), assessed up to 6 hours)